Stuttgart - Delayed Quote EUR
Ryvu Therapeutics SA (9Y4.SG)
7.40
-0.19
(-2.50%)
As of 3:01:34 PM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-129,479
-129,479
-84,550
21,319
-58,886
Investing Cash Flow
137,165
137,165
-195,541
690
8,055
Financing Cash Flow
94,209
94,209
240,833
-2,455
-2,152
End Cash Position
160,073
160,073
57,939
101,917
83,236
Capital Expenditure
-5,903
-5,903
-8,579
-9,287
-11,982
Issuance of Capital Stock
--
--
250,284
--
237
Issuance of Debt
94,656
94,656
127
--
--
Repayment of Debt
--
--
-747
-702
-791
Free Cash Flow
-135,382
-135,382
-93,129
12,032
-70,868
12/31/2021 - 12/1/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade